Bender RA

ORCID: 0000-0003-1210-8871 · 1 paper in corpus

2022

Medroxyprogesterone Acetate for Abnormal Uterine Bleeding Due to Ovulatory Dysfunction: The Effect of 2 Different-Duration Regimens.

Medical science monitor : international medical journal of experimental and clinical research ·doi:10.12659/msm.936727

BACKGROUND Abnormal uterine bleeding (AUB) lowers the quality of life of women. This study attempted to determine which treatment protocol of medroxyprogesterone acetate (MPA), 15 vs 10 day-administration in a luteal phase, provides better …